Y mAbs Therapeutics (YMAB) — Defensive Interval Ratio
Y mAbs Therapeutics (YMAB) has a Defensive Interval Ratio of 250 days as of June 2025. Defensive assets of $15.74 Million (cash $-, short-term investments $-, receivables $15.74 Million) cover 250 days of daily cash needs of $62.86K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Y mAbs Therapeutics Defensive Interval Ratio (2016–2024)
This chart shows how Y mAbs Therapeutics's Defensive Interval Ratio has evolved across 7 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 250 days, meaning defensive assets of $15.74 Million can fund 250 days of operations without new revenue. For the complete balance sheet picture, see balance sheet size of Y mAbs Therapeutics.
Annual Defensive Interval Ratio for Y mAbs Therapeutics (2016–2024)
The table below presents the year-by-year Defensive Interval Ratio for Y mAbs Therapeutics from 2016 to 2024, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See working capital position of Y mAbs Therapeutics to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 303 days | $19.69 Million | $64.93K/day | $- | $- | ▼ -104 days |
| 2023 | 407 days | $22.45 Million | $55.15K/day | $- | $- | ▲ +245 days |
| 2022 | 162 days | $12.53 Million | $77.49K/day | $- | $- | ▲ +61 days |
| 2021 | 101 days | $7.71 Million | $76.37K/day | $- | $- | ▲ +86 days |
| 2020 | 15 days | $800.00K | $53.52K/day | $- | $- | ▲ +13 days |
| 2017 | 1 days | $32.00K | $21.71K/day | $- | $32.00K | ▼ -2 days |
| 2016 | 3 days | $28.00K | $8.15K/day | $- | $28.00K | — |